# FDA WARNING_LETTER - http://www.ecigretail.com - Unknown Date

Source: https://www.keypedia.com/records/warning_letter/httpwwwecigretailcom/e5e01990-902a-43e7-8175-a50e813aac0f

> FDA WARNING_LETTER for http://www.ecigretail.com on Unknown Date. Product: Tobacco. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: http://www.ecigretail.com
- Product Type: Tobacco
- Office Name: Center for Tobacco Products
- Summary: The FDA issued a Warning Letter to David Taylor of ecigretail.com after reviewing their website and determining that Gamucci Menthol e-liquid products were offered for sale and distribution in the U.S. These e-liquids are classified as tobacco products under section 201(rr) of the FD&C Act.

The primary violation identified was the sale of Gamucci Menthol e-liquid to a person younger than 18 years of age, which constitutes misbranding under section 903(a)(7)(B) of the FD&C Act. This violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to minors. Covered tobacco products are defined under 21 C.F.R. § 1140.3 and deemed subject to Chapter IX of the FD&C Act by 21 C.F.R. § 1100.2.

The FDA requires immediate correction of this violation and similar issues to ensure compliance with the FD&C Act. Failure to comply may result in further actions, including civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Adulterated and misbranded tobacco products imported into the U.S. are subject to detention. A written response detailing corrective actions, including discontinuation dates of

## Related Officers

- [Director](https://www.keypedia.com/people/ann-simoneau/155ef03c-6b60-4063-b35d-75522fa67d2b)

Company: https://www.keypedia.com/companies/httpwwwecigretailcom/d7083ed5-bd51-4824-953e-5b6e99291de4

Office: https://www.keypedia.com/offices/center-for-tobacco-products/65f73cae-ef6f-4e9f-a311-a111daa67374